Ozmosi | HSK-55718 Drug Profile
Drug Profile
Using advanced filters...

HSK-55718

Alternative Names: HSK-55718, HSK55718, HSK 55718
Clinical Status: Active
Latest Update: 2026-07-21
Latest Update Note: Clinical Trial Update

Product Description

HSK55718 is an innovative small-molecule non-opioid analgesic drug independently researched by the company. It is expected to satisfy patients' pain control, reduce the occurrence of adverse reactions and avoid the risk of addiction, and bring safer and more effective analgesia options to patients with acute pain. According to the requirements for chemical drug registration classification in the notice issued by the State Drug Administration on the “Registration Classification of Chemical Drugs and Application Data Requirements” (No. 44 of 2020), this product is a chemical drug category. (Sourced from: https://www.webull.com/news/13673188842781696)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Company: AbbVie
Company Location: Eastern America
Company Founding Year: 2013
Additional Commercial Interests: Haisco

Clinical Description

Map of Global Clinical Trials for HSK-55718

Countries in Clinic: China

Active Clinical Trial Count: 3

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Abdominal Pain|Anesthesia Related|Morphine Dependence|Pain, Postoperative

Phase 1: Acute Pain

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

CTR20255036

CTR20255036

P1

Completed

Acute Pain

2026-06-10

2026-07-12

Patient Enrollment|Primary Completion Date|Study Completion Date|Treatments|Trial Status

NCT07533786

HSK55718-201

P2

Recruiting

Abdominal Pain|Morphine Dependence|Anesthesia Related|Pain, Postoperative

2026-11-22

12%

2026-05-29

Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments|Trial Status

NCT07551739

HSK55718-202

P2

Not yet recruiting

Morphine Dependence|Anesthesia Related|Pain, Postoperative

2026-11-01

12%

2026-04-28

Primary Endpoints|Treatments

Recent News Events

Date

Type

Title